Inferior vena cava filters market seen reaching $8.87 billion by 2030

The Business Research Company says the inferior vena cava filters market is projected to rise from $5.79 billion in 2025 to $8.87 billion by 2030, fueled by more surgical procedures, more minimally invasive care and broader use of retrievable filters. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Inferior vena cava filters are used to reduce the risk of pulmonary embolism in patients prone to blood clots. - The market’s projected growth points to rising demand for devices that support clot prevention during and after surgery. - Expanding use of minimally invasive treatments is increasing interest in lower-burden options for vascular care.

What happened: - The Business Research Company released a market report on the inferior vena cava filters market. - The report estimates the market at $5.79 billion in 2025. - The report projects the market will reach $6.29 billion in 2026. - The report forecasts the market will climb to $8.87 billion by 2030. - The report pegs the market’s 2025-2030 CAGR at 9.0%.

The details: - The market’s recent growth has been driven by more venous thromboembolism cases, more surgical interventions and wider use of interventional radiology techniques. - Growth has also been supported by hospital-based vascular care services and higher awareness of pulmonary embolism risks. - Future demand is expected to come from advanced retrievable filters, more post-implant monitoring and broader adoption of minimally invasive treatments. - An aging population with higher clotting risk is another expected driver. - Ongoing technology improvements in filter design are also expected to support growth. - The report defines an inferior vena cava filter as a small medical device that catches blood clots in the inferior vena cava before they can travel to the lungs. - By intercepting clots, the device lowers the risk of life-threatening pulmonary embolism. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western and Eastern Europe, South America, the Middle East and Africa. - The report adds new 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - Download a free sample of the report. - View the full market report.

Between the lines: - The report ties market expansion to procedures that reduce recovery time and tissue damage, which suggests device makers are benefiting from the broader shift toward less invasive care. - The regional split points to a mature North American market and a faster-ramping Asia-Pacific market with more room for device adoption. - The inclusion of forecasting dashboards and scoring tools signals that the report is aimed at buyers and investors looking for planning and comparison data, not just market size estimates.

What's next: - Demand is likely to track surgical volumes, clot-related diagnoses and adoption of retrievable filter technology. - Future growth will likely depend on how quickly hospitals adopt minimally invasive approaches and post-procedure monitoring practices. - Regional gains are expected to be strongest in Asia-Pacific as healthcare infrastructure and medical technology investment improve. - The market will continue to be shaped by device innovation and prevention of pulmonary embolism in high-risk patients.